HEAD AND NECK CANCERS HYPOPHARYNX

Clinical trials for HEAD AND NECK CANCERS HYPOPHARYNX explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK CANCERS HYPOPHARYNX trials appear

Sign up with your email to follow new studies for HEAD AND NECK CANCERS HYPOPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets tough cancers after other treatments fail

Disease control Recruiting now

This early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…

Matched conditions: HEAD AND NECK CANCERS HYPOPHARYNX

Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

HEAD AND NECK CANCERS HYPOPHARYNX

Get alerted when new HEAD AND NECK CANCERS HYPOPHARYNX trials appear

New pill targets tough cancers after other treatments fail